DexCom, Inc. - Common Stock (NQ:DXCM)

86.90 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

50 51 Next >

Micron, Dropbox And 2 Other Stocks Insiders Are Selling ↗

April 01, 2024

The Nasdaq 100 closed lower by around 0.1% on Thursday. Investors, meanwhile, focused on some notable insider trades.

Via Benzinga

Market Cap Game Show: Andy Cross vs. Bill Mann ↗

March 30, 2024

Join the "Rule Breaker Investing" fun.

Via The Motley Fool

DexCom Inc Chart Analysis ↗

March 26, 2024

Technical analysis of the stock chart for DXCM.

Via Talk Markets

Dexcom Stock Shows Market Leadership, Gets Rating Upgrade. Prognosis Good. ↗

March 26, 2024

Among its other key ratings Dexcom has a near-best 98 Earnings Per Share Rating out of 99, reflecting strong profit growth this past year.

Via Investor's Business Daily

Two Hot AI Stocks Lead S&P 500 Monday ↗

March 25, 2024

Super Micro and Micron , two big winners in 2024, led the way Monday.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

Here's How Much $1000 Invested In DexCom 15 Years Ago Would Be Worth Today ↗

March 25, 2024

Via Benzinga

NASDAQ:DXCM—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

March 21, 2024

DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating.

Via Chartmill

DexCom's Options: A Look at What the Big Money is Thinking ↗

March 20, 2024

Via Benzinga

More Than 86% of Analysts Who Cover These 3 Stocks Rate Them a ‘Buy’ ↗

March 25, 2024

Investors should take notice of these stocks with high analyst ratings. It's time to load up your portfolio.

Via InvestorPlace

S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind ↗

March 23, 2024

DexCom, Blackstone and Royal Caribbean head this list of five stocks.

Via Investor's Business Daily

Topics Economy Stocks

Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark ↗

March 19, 2024

The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81.

Via Investor's Business Daily

DexCom Stock Trying To Close In On Key Technical Benchmark ↗

March 18, 2024

In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years ↗

March 14, 2024

Via Benzinga

Analyst Expectations For DexCom's Future ↗

March 12, 2024

Via Benzinga

DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says ↗

March 12, 2024

DexCom Inc’s (NASDAQ: DXCM) Stelo Glucose Biosensor System has been approved by the Food and Drug Administration (FDA) as the first over-the-counter (OTC)

Via Benzinga

Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher ↗

March 11, 2024

On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78.

Via Investor's Business Daily

ServiceNow Setting Up As Three Stocks Flash Buy Signals ↗

March 09, 2024

All four stocks to watch boast solid earnings growth.

Via Investor's Business Daily

2 Medical Device Stocks to Buy Hand Over Fist in March ↗

March 08, 2024

Don't let their modest gains over the past year mislead you; these stocks can make for great long-term investments.

Via The Motley Fool

Palantir Technologies, SL Green Realty And A Healthcare Stock On CNBC's 'Final Trades' ↗

March 07, 2024

On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named SL Green Realty Corp.

Via Benzinga

FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's ↗

March 06, 2024

FDA greenlights DexCom's Stelo, the first OTC continuous glucose monitor for non-insulin-dependent diabetics. Competitive pricing, potential HSA benefits, and market expansion make it a significant...

Via Benzinga

Stocks Surge, Gold Hits New All-Time High, Bitcoin Reclaims $67,000 As Powell Reassures Wall Street: What's Driving Markets Wednesday? ↗

March 06, 2024

Markets rallied across the board on Wednesday, erasing the uptick in volatility seen in the previous session, following reassurances from Fed Chair Jerome Powell regarding the Fed’s willingness to ease...

Via Benzinga

Topics Economy

Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win ↗

March 06, 2024

The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it.

Via Investor's Business Daily

FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription ↗

March 06, 2024

FDA-approved Dexcom Stelo: Over-the-counter glucose monitoring for non-insulin users. Stelo, the first OTC CGM, available online without prescription from summer 2024. Continuous glucose tracking with...

Via Benzinga

Campbell Soup, Box And 3 Stocks To Watch Heading Into Wednesday ↗

March 06, 2024

With U.S. stock futures trading mostly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Stelo by Dexcom First Glucose Biosensor to be Cleared by FDA as Over-the-Counter

March 05, 2024

From DexCom, Inc.

Via Business Wire

Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move ↗

March 03, 2024

With patience, these stocks will provide outsized returns to investors.

Via The Motley Fool

Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla ↗

March 01, 2024

U.S. stock market continues bull run, hitting record highs for S&P 500 and Nasdaq 100. SPY ETF surpasses $500 billion AUM, with other companies also reaching milestones.

Via Benzinga

Topics ETFs Stocks

3 Telehealth Stocks With Room to Run in 2024 ↗

February 29, 2024

Embrace 2024's leading telehealth stocks to buy, merging cutting-edge care with smart investing for a lucrative portfolio.

Via InvestorPlace

Dexcom Announces Upcoming Conference Presentation

February 27, 2024

From DexCom, Inc.

Via Business Wire

< Previous 1 2

...

26 27 28 29 30 31 32 33 34

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.